Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
House Digest on MSN
The Dollar Tree item that's popular for its fun design & DIY potential
If you're a DIY fan, there's one unexpected Dollar Tree item you have to check out thanks to its endless potential for a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results